Table 1 Background characteristics of the study participants (n = 37)
Total n = 37 | |||
|---|---|---|---|
Median | IQR | ||
Age (years) | 52 | 44–61 | |
Body mass at baseline (kg) | 53.6 | 49.1–58.2 | |
Body fat mass at baseline (kg) | 15.3 | 11.8–19.2 | |
BMI at baseline (kg/m2) | 21.7 | 19.2–23.3 | |
n | % | ||
Disease | Right breast cancer | 18 | 48.6 |
Left breast cancer | 12 | 32.4 | |
Bilateral breast cancer | 7 | 18.9 | |
Purpose of the treatment | Neoadjuvant | 15 | 40.5 |
Adjuvant | 15 | 40.5 | |
Recurrence or advanced | 7 | 18.9 | |
Disease stage | I | 7 | 18.9 |
II | 18 | 48.6 | |
III | 5 | 13.5 | |
IV | 7 | 18.9 | |
Disease subtype | ER + /Her2 − | 17 | 45.9 |
ER − /Her2 + | 3 | 8.1 | |
ER + /Her2 + | 17 | 45.9 | |
Chemotherapy regimen | T | 15 | 40.5 |
THP | 17 | 45.9 | |
TCbHP | 3 | 8.1 | |
TC | 2 | 5.4 | |
Her2 status | Her2 + | 20 | 54.1 |
Her2 − | 17 | 45.9 | |
Menopausal status | Pre-menopausal | 18 | 48.6 |
Post-menopausal | 19 | 51.4 | |
Smoker | Yes | 8 | 21.6 |
No | 29 | 78.4 | |
History of alcohol consumption | Yes | 11 | 29.7 |
No | 26 | 70.3 | |
Use of diuretics | Yes | 7 | 18.9 |
No | 30 | 81.1 | |
Marital status | Yes | 19 | 51.4 |
No | 18 | 48.6 | |
In employment | Yes | 15 | 40.5 |
No | 22 | 59.5 | |
Educational background | Junior high school | 2 | 5.4 |
High school | 9 | 24.3 | |
College school | 8 | 21.6 | |
Undergraduate or above | 17 | 45.9 | |
No answer | 1 | 2.7 | |
Income | < 2 million yen p.a | 4 | 10.8 |
2–6 million yen p.a | 13 | 35.1 | |
> 6 million yen p.a | 7 | 18.9 | |
No answer | 13 | 35.1 | |